Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study.Published in:Breast Cancer (13406868), 2019, v. 26, n. 1, p. 39, doi. 10.1007/s12282-018-0887-zBy:Noguchi, Emi;Tamura, Kenji;Hattori, Masaya;Horiguchi, Jun;Sato, Nobuaki;Kanatani, Kazumitsu;Matsunaga, Kiyoshi;Iwata, Hiroji;Fujiwara, YasuhiroPublication type:Article
Ethnic sensitivity assessment of the antibody-drug conjugate trastuzumab emtansine (T-DM1) in patients with HER2-positive locally advanced or metastatic breast cancer.Published in:2016By:Li, Chunze;Wang, Bei;Lu, Dan;Jin, Jin;Gao, Yuying;Matsunaga, Kiyoshi;Igawa, Yuriko;Nijem, Ihsan;Lu, Michael;Strasak, Alexander;Chernyukhin, Nataliya;Girish, Sandhya;Jin, Jin YPublication type:journal article